001060.KS
JW Pharmaceutical Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 27,150.00
−2.16%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 7.49x
- P/E 2027E
- 6.91x
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 6.48x
- PEG TTM
- 0.25x
- Price / book
- 1.60x
- Price / sales
- 0.80x
- Price / cash flow
- 4.87x
Enterprise value
- Enterprise value
- KRW 670.7B
- EV / sales
- 0.82x
- EV / EBITDA
- 5.33x
- EV / EBIT
- 5.86x
- Market cap
- KRW 655.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026